Organic Letters
Letter
Z.; Chinoy, Z. S.; Ambre, S. G.; Peng, W.; McBride, R.; deVries, R. P.;
Glushka, J.; Paulson, J. C.; Boons, G.-J. Science 2013, 341, 379.
(c) Chen, Y.; Li, Y.; Yu, H.; Sugiarto, G.; Thon, V.; Hwang, J.; Ding,
L.; Hie, L.; Chen, X. Angew. Chem., Int. Ed. 2013, 52, 11852. (d) Xu,
Y.; Cai, C.; Chandarajoti, K.; Hsieh, P.-H.; Li, L.; Pham, T. Q.;
Sparkenbaugh, E. M.; Sheng, J.; Key, N. S.; Pawlinski, R.; Harris, E. N.;
Linhardt, R. J.; Liu, J. Nat. Chem. Biol. 2014, 10, 248.
(7) (a) Curran, D. P. Angew. Chem., Int. Ed. 1998, 37, 1175.
(b) Studer, A.; Hadida, S.; Ferritto, R.; Kim, S. Y.; Jeger, P.; Wipf, P.;
Curran, D. P. Science 1997, 275, 823.
temperature or 3 N aqueous HCl at 60 °C for 2 h. We observed
that while 3 N HCl removed the fluorous tag from
tetrasaccharide (17), it also resulted in complete sulfate loss.
Treatment of the model substrate 3 with 50% aqueous TFA
only afforded a 10% yield even for 24 h. Finally, superheated
water (liquid water between 100 and 374 °C),24 a green
F
solvent, was successfully employed to remove Boc tag from
substrates 17 and 18, and the HS tetrasaccharide (1) and
hexasaccharide (2) were obtained after N-acetylation.
F
In conclusion, we have successfully applied the Boc linker
(8) Curran, D. P. Science 2008, 321, 1645.
(9) (a) Brittain, S. M.; Ficarro, S. B.; Brock, A.; Peters, E. C. Nat.
Biotechnol. 2005, 23, 463. (b) Evanko, D. Nat. Meth. 2005, 2, 406.
(10) (a) Filippov, D. V.; van Zoelen, D. J.; Oldfield, S. P.; van der
Marel, G. A.; Overkleeft, H. S.; Drijfhout, J. W.; van Boom, J. H.
Tetrahedron Lett. 2002, 43, 7809. (b) Mizuno, M.; Goto, K.; Miura, T.;
Hosaka, D.; Inazu, T. Chem. Commun. 2003, 39, 972.
(11) (a) Ko, K.-S.; Jaipuri, F. A.; Pohl, N. L. J. Am. Chem. Soc. 2005,
127, 13162. (b) Pohl, N. L. Angew. Chem., Int. Ed. 2008, 47, 3868.
(c) Chen, G.-S.; Pohl, N. L. Org. Lett. 2008, 10, 785.
(12) Zhang, W. Tetrahedron Lett. 2003, 59, 4475.
and FSPE technique in our chemoenzymatic synthesis of
heparan sulfate oligosaccharides. The fluorous-linked disacchar-
ide was extended with glycosyltransferases KifA and PmHS2
respectively, and recognized by 6-OSTs, revealing that the FBoc
linker does not interfere with the action of these enzymes. The
FSPE technique was suitable for the purification of heparan
sulfate oligosaccharides as well. Currently, additional bio-
synthetic enzymes, including C5-epimerase, 2-OST and 3-OST,
are under investigation to regioselectively add additional sulfate
groups on these HS backbones.6c
(13) Palmacci, E. R.; Hewitt, M. C.; Seeberger, P. H. Angew. Chem.,
Int. Ed. 2001, 40, 4433.
(14) Yang, B.; Jing, Y.; Huang, X. Eur. J. Org. Chem. 2010, 2010,
1290.
(15) Jaipuri, F. A.; Pohl, N. L. Org. Biomol. Chem. 2008, 6, 2686.
(16) Jaipuri, F. A.; Collet, B. Y. M.; Pohl, N. L. Angew. Chem., Int. Ed.
2008, 47, 1707.
(17) Zong, C.; Venot, A.; Dhamale, O.; Boons, G.-J. Org. Lett. 2013,
15, 342.
(18) (a) Cai, C.; Li, L.; Harvey, C.; Liu, J.; Linhardt, R. J. Tetrahedron
Lett. 2013, 54, 4471. (b) Cai, C.; Edgar, K.; Liu, J.; Linhardt, R. J.
Carbohydr. Res. 2013, 372, 30.
(19) Luo, Z.; Williams, J.; Read, R. W.; Curran, D. P. J. Org. Chem.
2001, 66, 4261.
(20) Liu, R.; Xu, Y.; Chen, M.; Weïwer, M.; Zhou, X.; Bridges, A. S.;
DeAngelis, P. L.; Zhang, Q.; Linhardt, R. J.; Liu, J. J. Biol. Chem. 2010,
285, 34240.
ASSOCIATED CONTENT
■
S
* Supporting Information
1
1
1H, 13C, H−1H COSY, H−13C HMQC NMR, and ESI MS
spectra and experimental procedures for the preparation of
compounds. This material is available free of charge via the
AUTHOR INFORMATION
Corresponding Author
■
3405.
Notes
(21) Lohman, G. J. S.; Hunt, D. K.; Ho, J. A.; Seeberger, P. H. J. Org.
Chem. 2003, 68, 7559.
The authors declare no competing financial interest.
(22) (a) De Mico, A.; Margarita, R.; Parlanti, L.; Vescovi, A.;
Piancatelli, G.; Sapienza, L. J. Org. Chem. 1997, 62, 6974. (b) van den
Bos, L. J.; Codee, J. D. C.; van der Toorn, J. C.; Boltje, T. J.; van
́
Boom, J. H.; Overkleeft, H. S.; van der Marel, G. A. Org. Lett. 2004, 6,
2165.
(23) Kuberan, B.; Lech, M. Z.; Beeler, D. L.; Wu, Z. L.; Rosenberg, R.
D. Nat. Biotechnol. 2003, 21, 1343.
(24) (a) Wang, J.; Liang, Y.-L.; Qu, J. Chem. Commun. 2009, 45,
5144. (b) Wang, G.; Li, C.; Li, J.; Jia, X. Tetrahedron Lett. 2009, 50,
1438. (c) Zinelaabidine, C.; Souad, O.; Zoubir, J.; Malika, B.; Nour-
Eddine, A. Int. J. Chem. 2012, 4, 73.
ACKNOWLEDGMENTS
■
We gratefully acknowledge support from the National Institutes
of Health in the form of Grant Nos. HL62244, HL094463,
HL096972, and GM102137.
REFERENCES
■
(1) (a) Hook, M.; Kjellen
́
, L.; Johansson, S.; Robinson, J. Annu. Rev.
̈
̈
Biochem. 1984, 53, 849. (b) Sasisekharan, R.; Raman, R.; Prabhakar, V.
Annu. Rev. Biomed. Eng. 2006, 8, 181. (c) Esko, J. D.; Kimata, K.;
Lindahl, U. In Essentials of Glycobiology, 2nd ed.; Varki, A., Cummings,
R., Esko, J., Freeze, H., Hard, G., Marth, J., Eds.; Cold Spring Harbor
Laboratory Press: Cold Spring Harbor, 1999; p 229.
(2) Gandhi, N. S.; Mancera, R. L. Drug Discovery Today 2010, 15,
1058.
(3) (a) Lindahl, U. Thromb. Haemostasis 1991, 1, 44. (b) Casu, B.;
Lindahl, U. In Advances in Carbohydrate Chemistry and Biochemistry;
Horton, D., Ed.; Elsevier: San Diego, CA, 2001; Vol. 57, p 159.
(c) Bishop, J. R.; Schuksz, M.; Esko, J. D. Nature 2007, 446, 1030.
(4) (a) Capila, I.; Linhardt, R. J. Angew. Chem., Int. Ed. 2002, 41, 390.
(b) Gandhi, N. S.; Mancera, R. L. Chem. Biol. Drug Des. 2008, 72, 455.
(5) (a) Karst, N. A.; Linhardt, R. J. Curr. Med. Chem. 2003, 10, 1993.
́
(b) Codee, J. D. C.; Overkleeft, H. S.; van der Marel, G. A.; van
Boeckel, C. A. A. Drug Discovery Today 2004, 1, 317. (c) Weïwer, M.;
Linhardt, R. J. In Comprehensive Glycoscience, 1st ed.; Boons, G. J., Lee,
Y. C., Suzuki, A., Taniguchi, N., Voragen, G. J., Kamerling, J. P., Eds.;
Elsevier BV: Amsterdam, 2007; Vol. 1, p 713.
(6) (a) Xu, Y.; Masuko, S.; Takieddin, M.; Xu, H.; Liu, R.; Jing, J.;
Mousa, S. A.; Linhardt, R. J.; Liu, J. Science 2011, 334, 498. (b) Wang,
2243
dx.doi.org/10.1021/ol500738g | Org. Lett. 2014, 16, 2240−2243